ALLOVIR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7233 USD | -7.27% |
|
-2.69% | +6.40% |
| 11/06 | AlloVir, Inc. Enter into Termination of Sublease Agreement with AMAG Pharmaceuticals, Inc | CI |
| 13/05 | AlloVir, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar AlloVir, Inc.
7e69cc6aaedef52add41306629a53.HFCDR9FJdHTtfzF91JnNr9Og-eSgaBbnbvK1wo-AWk8.ZB67MpQARwCuHFAultCO9oHFr4n2USKhArjAu9bCCCdkIPYlvgMMBpscCQ~aa846be7ed703085944c369efe9932bb
Upcoming events on AlloVir, Inc.
Past events on AlloVir, Inc.
| 06/06/2024 06:30 pm | Annual General Meeting |
| 28/11/2023 08:30 pm | Piper Sandler Healthcare Conference |
| 02/11/2023 04:30 pm | Q3 2023 Earnings Release |
| 12/09/2023 09:30 pm | H.C. Wainwright Global Investment Conference |
| 12/09/2023 02:25 am | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 03/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 11/05/2023 06:30 pm | Annual General Meeting |
| 09/05/2023 09:10 pm | Bank of America Healthcare Conference - Fireside Chat |
| 04/05/2023 04:30 pm | Q1 2023 Earnings Release |
| 15/02/2023 07:30 pm | Posoleucel Phase 2 Study Results Call |
| 15/02/2023 05:37 pm | FY 2022 Earnings Release |
| 14/02/2023 08:30 pm | SVB Securities Global Biopharma Conference |
| 11/01/2023 03:45 am | JP Morgan Healthcare Conference |
| 15/12/2022 03:00 am | Business Update Call |
| 11/12/2022 03:45 am | American Society of Hematology Meeting |
| 29/11/2022 10:30 pm | Piper Sandler Healthcare Conference |
| 05/11/2022 | American Society of Nephrology Kidney Week Conference - Abstract SA-PO849 |
| 03/11/2022 04:30 pm | Q3 2022 Earnings Release |
| 14/09/2022 09:50 pm | Morgan Stanley Global Healthcare Conference |
| 04/08/2022 04:30 pm | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,17 | 0,00 0,38 - | 0,00 0,38 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -71,2 -70,3 -1.36% | -170 -153 -11.11% | -170 -174 1.75% | -200 -189 -5.62% | -54,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -71,3 -72,3 1.36% | -170 -160 -5.95% | -171 -177 3.43% | -200 -189 -5.51% | -60,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -69,8 -71,9 2.97% | -171 -165 -3.71% | -169 -180 6.01% | -191 -179 -6.44% | -41,0 |
|
Net income Million USD | Released Forecast Spread | -23,8 | -69,8 -72,1 3.19% | -172 -165 -4.23% | -169 -181 6.88% | -190 -180 -5.8% | -45,4 |
|
EPS USD | Released Forecast Spread | -12,4 | -2,59 -4,52 42.64% | -2,74 -2,64 -3.93% | -2,20 -2,25 2.08% | -1,83 -1,73 -5.83% | -0,39 |
| Announcement Date | 03/06/20 | 11/02/21 | 10/02/22 | 15/02/23 | 15/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -44,5 -48,0 7.21% | -42,9 -47,0 8.8% | -40,3 -45,0 10.34% | -47,2 -44,0 -7.32% | -46,9 -44,0 -6.53% | -62,3 -47,0 -32.48% | -32,3 -22,0 -46.81% | -11,0 | -6,00 | -3,00 | ||||
|
EBIT Million USD | Released Forecast Spread | -43,2 -50,5 14.47% | -44,6 -47,6 6.15% | -43,0 -48,8 11.9% | -40,4 -49,5 18.32% | -43,2 -43,3 0.04% | -47,3 -45,9 -3.17% | -47,0 -45,3 -3.59% | -69,2 -53,2 -30.09% | -32,3 -22,0 -46.81% | -11,0 | -6,00 | -3,00 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -43,9 -51,1 14.11% | -44,5 -47,9 7.09% | -42,1 -48,7 13.58% | -38,6 -49,1 21.42% | -41,2 -43,0 4.16% | -45,3 -44,8 -0.98% | -44,3 -46,0 3.72% | -59,8 -48,7 -22.95% | -30,3 -22,0 -37.72% | -11,0 | -6,00 | -3,00 | ||
|
Net income Million USD | Released Forecast Spread | -43,9 -50,5 13.19% | -44,6 -47,1 5.15% | -42,1 -46,8 10.18% | -38,1 -50,5 24.5% | -41,2 -42,9 3.94% | -45,3 -44,1 -2.62% | -44,3 -44,0 -0.59% | -59,8 -48,8 -22.55% | -30,3 -19,4 -56.33% | -7,65 | -4,38 | -2,48 | ||
|
EPS USD | Released Forecast Spread | -0,69 -0,80 13.32% | -0,69 -0,73 5.52% | -0,50 -0,53 5% | -0,37 -0,54 31.9% | -0,44 -0,46 4.68% | -0,48 -0,44 -9.06% | -0,39 -0,40 2.86% | -0,53 -0,43 -24% | -0,26 -0,17 -52.44% | -0,07 | -0,03 | -0,02 | ||
| Announcement Date | 05/05/22 | 04/08/22 | 03/11/22 | 15/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 15/03/24 | 13/05/24 | - | - | - | - | - |
More events
Past sector events for AlloVir, Inc.
| 05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALVR Stock
- Calendar AlloVir, Inc.
